This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jenssen, H.
Right arrow Articles by Hancock, R. E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenssen, H.
Right arrow Articles by Hancock, R. E. W.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, July 2006, p. 491-511, Vol. 19, No. 3
0893-8512/06/$08.00+0     doi:10.1128/CMR.00056-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Peptide Antimicrobial Agents

Håvard Jenssen, Pamela Hamill, and Robert E. W. Hancock*

Centre for Microbial Diseases and Immunity Research, University of British Columbia, Lower Mall Research Station, 232-2259 Lower Mall, Vancouver, British Columbia V6T 1Z4, Canada

Antimicrobial host defense peptides are produced by all complex organisms as well as some microbes and have diverse and complex antimicrobial activities. Collectively these peptides demonstrate a broad range of antiviral and antibacterial activities and modes of action, and it is important to distinguish between direct microbicidal and indirect activities against such pathogens. The structural requirements of peptides for antiviral and antibacterial activities are evaluated in light of the diverse set of primary and secondary structures described for host defense peptides. Peptides with antifungal and antiparasitic activities are discussed in less detail, although the broad-spectrum activities of such peptides indicate that they are important host defense molecules. Knowledge regarding the relationship between peptide structure and function as well as their mechanism of action is being applied in the design of antimicrobial peptide variants as potential novel therapeutic agents.

* Corresponding author. Mailing address: Centre for Microbial Diseases and Immunity Research, University of British Columbia, Lower Mall Research Station, 232-2259 Lower Mall, Vancouver, British Columbia V6T 1Z4, Canada. Phone: (604) 822-2682. Fax: (604) 827-5566. E-mail: bob{at}cmdr.ubc.ca.

Clinical Microbiology Reviews, July 2006, p. 491-511, Vol. 19, No. 3
0893-8512/06/$08.00+0     doi:10.1128/CMR.00056-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Oyston, P. C. F., Fox, M. A., Richards, S. J., Clark, G. C. (2009). Novel peptide therapeutics for treatment of infections. J Med Microbiol 58: 977-987 [Abstract] [Full Text]  
  • Evans, D. L., Connor, M. A., Moss, L. D., Lackay, S., Leary, J. H. III, Krunkosky, T., Jaso-Friedmann, L. (2009). Cellular expression and antimicrobial function of a phylogenetically conserved novel histone 1x-like protein on mouse cells: a potential new class of pattern recognition receptor. J. Leukoc. Biol. 86: 133-141 [Abstract] [Full Text]  
  • Jang, S. A, Sung, B. H., Cho, J. H., Kim, S. C. (2009). Direct Expression of Antimicrobial Peptides in an Intact Form by a Translationally Coupled Two-Cistron Expression System. Appl. Environ. Microbiol. 75: 3980-3986 [Abstract] [Full Text]  
  • Tharntada, S., Ponprateep, S., Somboonwiwat, K., Liu, H., Soderhall, I., Soderhall, K., Tassanakajon, A. (2009). Role of anti-lipopolysaccharide factor from the black tiger shrimp, Penaeus monodon, in protection from white spot syndrome virus infection. J. Gen. Virol. 90: 1491-1498 [Abstract] [Full Text]  
  • Boyce, J. D., Harper, M., St. Michael, F., John, M., Aubry, A., Parnas, H., Logan, S. M., Wilkie, I. W., Ford, M., Cox, A. D., Adler, B. (2009). Identification of Novel Glycosyltransferases Required for Assembly of the Pasteurella multocida A:1 Lipopolysaccharide and Their Involvement in Virulence. Infect. Immun. 77: 1532-1542 [Abstract] [Full Text]  
  • Jung, S., Dingley, A. J., Augustin, R., Anton-Erxleben, F., Stanisak, M., Gelhaus, C., Gutsmann, T., Hammer, M. U., Podschun, R., Bonvin, A. M. J. J., Leippe, M., Bosch, T. C. G., Grotzinger, J. (2009). Hydramacin-1, Structure and Antibacterial Activity of a Protein from the Basal Metazoan Hydra. J. Biol. Chem. 284: 1896-1905 [Abstract] [Full Text]  
  • Flemming, K., Klingenberg, C., Cavanagh, J. P., Sletteng, M., Stensen, W., Svendsen, J. S., Flaegstad, T. (2009). High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms. J Antimicrob Chemother 63: 136-145 [Abstract] [Full Text]  
  • Sato, H., Feix, J. B. (2008). Lysine-Enriched Cecropin-Mellitin Antimicrobial Peptides with Enhanced Selectivity. Antimicrob. Agents Chemother. 52: 4463-4465 [Abstract] [Full Text]  
  • Drake, P. M., Nathan, J. K., Stock, C. M., Chang, P. V., Muench, M. O., Nakata, D., Reader, J. R., Gip, P., Golden, K. P. K., Weinhold, B., Gerardy-Schahn, R., Troy, F. A. II, Bertozzi, C. R. (2008). Polysialic Acid, a Glycan with Highly Restricted Expression, Is Found on Human and Murine Leukocytes and Modulates Immune Responses. J. Immunol. 181: 6850-6858 [Abstract] [Full Text]  
  • Dai, C., Ma, Y., Zhao, Z., Zhao, R., Wang, Q., Wu, Y., Cao, Z., Li, W. (2008). Mucroporin, the First Cationic Host Defense Peptide from the Venom of Lychas mucronatus. Antimicrob. Agents Chemother. 52: 3967-3972 [Abstract] [Full Text]  
  • Gryllos, I., Tran-Winkler, H. J., Cheng, M.-F., Chung, H., Bolcome, R. III, Lu, W., Lehrer, R. I., Wessels, M. R. (2008). Induction of group A Streptococcus virulence by a human antimicrobial peptide. Proc. Natl. Acad. Sci. USA 105: 16755-16760 [Abstract] [Full Text]  
  • Diamond, G., Beckloff, N., Ryan, L.K. (2008). Host Defense Peptides in the Oral Cavity and the Lung: Similarities and Differences. JDR 87: 915-927 [Abstract] [Full Text]  
  • Lisanby, M. W., Swiecki, M. K., Dizon, B. L. P., Pflughoeft, K. J., Koehler, T. M., Kearney, J. F. (2008). Cathelicidin Administration Protects Mice from Bacillus anthracis Spore Challenge. J. Immunol. 181: 4989-5000 [Abstract] [Full Text]  
  • White, J. H. (2008). Vitamin D Signaling, Infectious Diseases, and Regulation of Innate Immunity. Infect. Immun. 76: 3837-3843 [Full Text]  
  • Wang, G., Watson, K. M., Buckheit, R. W. Jr. (2008). Anti-Human Immunodeficiency Virus Type 1 Activities of Antimicrobial Peptides Derived from Human and Bovine Cathelicidins. Antimicrob. Agents Chemother. 52: 3438-3440 [Abstract] [Full Text]  
  • Gooderham, W. J., Bains, M., McPhee, J. B., Wiegand, I., Hancock, R. E. W. (2008). Induction by Cationic Antimicrobial Peptides and Involvement in Intrinsic Polymyxin and Antimicrobial Peptide Resistance, Biofilm Formation, and Swarming Motility of PsrA in Pseudomonas aeruginosa. J. Bacteriol. 190: 5624-5634 [Abstract] [Full Text]  
  • Bucki, R., Namiot, D. B., Namiot, Z., Savage, P. B., Janmey, P. A. (2008). Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13. J Antimicrob Chemother 62: 329-335 [Abstract] [Full Text]  
  • Beiter, K., Wartha, F., Hurwitz, R., Normark, S., Zychlinsky, A., Henriques-Normark, B. (2008). The Capsule Sensitizes Streptococcus pneumoniae to {alpha}-Defensins Human Neutrophil Proteins 1 to 3. Infect. Immun. 76: 3710-3716 [Abstract] [Full Text]  
  • Pranting, M., Negrea, A., Rhen, M., Andersson, D. I. (2008). Mechanism and Fitness Costs of PR-39 Resistance in Salmonella enterica Serovar Typhimurium LT2. Antimicrob. Agents Chemother. 52: 2734-2741 [Abstract] [Full Text]  
  • Rotem, S., Radzishevsky, I. S., Bourdetsky, D., Navon-Venezia, S., Carmeli, Y., Mor, A. (2008). Analogous oligo-acyl-lysines with distinct antibacterial mechanisms. FASEB J. 22: 2652-2661 [Abstract] [Full Text]  
  • Hawrani, A., Howe, R. A., Walsh, T. R., Dempsey, C. E. (2008). Origin of Low Mammalian Cell Toxicity in a Class of Highly Active Antimicrobial Amphipathic Helical Peptides. J. Biol. Chem. 283: 18636-18645 [Abstract] [Full Text]  
  • Akkarawongsa, R., Potocky, T. B., English, E. P., Gellman, S. H., Brandt, C. R. (2008). Inhibition of Herpes Simplex Virus Type 1 Infection by Cationic {beta}-Peptides. Antimicrob. Agents Chemother. 52: 2120-2129 [Abstract] [Full Text]  
  • Chongsiriwatana, N. P., Patch, J. A., Czyzewski, A. M., Dohm, M. T., Ivankin, A., Gidalevitz, D., Zuckermann, R. N., Barron, A. E. (2008). Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc. Natl. Acad. Sci. USA 105: 2794-2799 [Abstract] [Full Text]  
  • Bucki, R., Sostarecz, A. G., Byfield, F. J., Savage, P. B., Janmey, P. A. (2007). Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum. J Antimicrob Chemother 60: 535-545 [Abstract] [Full Text]  
  • Mount, K. L. B., Townsend, C. A., Bauer, M. E. (2007). Haemophilus ducreyi Is Resistant to Human Antimicrobial Peptides. Antimicrob. Agents Chemother. 51: 3391-3393 [Abstract] [Full Text]  
  • Harper, M., Boyce, J. D., Cox, A. D., St. Michael, F., Wilkie, I. W., Blackall, P. J., Adler, B. (2007). Pasteurella multocida Expresses Two Lipopolysaccharide Glycoforms Simultaneously, but Only a Single Form Is Required for Virulence: Identification of Two Acceptor-Specific Heptosyl I Transferases. Infect. Immun. 75: 3885-3893 [Abstract] [Full Text]  
  • Ceraul, S. M., Dreher-Lesnick, S. M., Gillespie, J. J., Rahman, M. S., Azad, A. F. (2007). New Tick Defensin Isoform and Antimicrobial Gene Expression in Response to Rickettsia montanensis Challenge. Infect. Immun. 75: 1973-1983 [Abstract] [Full Text]  
  • Seebah, S., Suresh, A., Zhuo, S., Choong, Y. H., Chua, H., Chuon, D., Beuerman, R., Verma, C. (2007). Defensins knowledgebase: a manually curated database and information source focused on the defensins family of antimicrobial peptides. Nucleic Acids Res 35: D265-D268 [Abstract] [Full Text]  
  • Kwakman, P. H. S., te Velde, A. A., Vandenbroucke-Grauls, C. M. J. E., van Deventer, S. J. H., Zaat, S. A. J. (2006). Treatment and Prevention of Staphylococcus epidermidis Experimental Biomaterial-Associated Infection by Bactericidal Peptide 2. Antimicrob. Agents Chemother. 50: 3977-3983 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»